Drugs / S. Flexneri-S. Sonnei bivalent conjugate vaccine
S. Flexneri-S. Sonnei bivalent conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06838195 | May 2025 → Jul 2028 expected | shigellosis | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S. Flexneri-S. Sonnei bivalent conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06838195 ↗ |
| Modality | Vaccine | “S. Flexneri-S. Sonnei bivalent conjugate vaccine” NCT06838195 ↗ |